Immunology

COVID-19 vaccines produce antibody response in the nasal mucosa

Respiratory viruses are known for their ability to enter the body through the eyes, nose, or mouth. Our bodies know that too. The nasal cavity is well-equipped with sticky mucus that traps pathogens and serves as an important ...

Medical research

Developing mucosal vaccines for respiratory viruses

Vaccines that provide long-lasting protection against influenza, coronaviruses and respiratory syncytial virus (RSV) have proved exceptionally difficult to develop. In a new review article in Cell Host & Microbe, researchers ...

Diseases, Conditions, Syndromes

How SARS-CoV-2 reaches the brain

Using post-mortem tissue samples, a team of researchers from Charité - Universitätsmedizin Berlin have studied the mechanisms by which the novel coronavirus can reach the brains of patients with COVID-19, and how the immune ...

Diseases, Conditions, Syndromes

'Hotspots' of a SARS-CoV-2 infection in the human body

An infection with the coronavirus SARS-CoV-2 can affect multiple organs. With this in mind, researchers of the German Center for Neurodegenerative Diseases (DZNE) and Cornell University in the US have investigated cellular ...

Surgery

Spinal cord mass arising from neural stem cell therapy

A spinal mass was identified in a young woman with complete spinal cord injury 8 years after she had undergone implantation of olfactory mucosal cells in the hopes of regaining sensory and motor function. The case is reported ...

Medications

Successful test in humans of a nasal vaccine against pertussis

The CHILD-INNOVAC European research programme, coordinated by Inserm, has enabled the development of an innovative vaccine that can be administered intranasally, to combat pertussis, which has shown a resurgence in developed ...

page 1 from 1